News

A new transatlantic alliance showcased its ambition to develop diagnostics for 8,000 rare diseases and double the number of registered Orphan drugs for rare conditions by 2020, at the Biotechnology Industry Organization (BIO) meeting in Washington

As it prepares to launch €418 million of new calls, the Commission says the bureaucracy-lite public-private projects set up in the economic emergency will be a model for research funding in the future

A new report points to a lack of confidence among life sciences executives about the quality of innovation programmes